| Product Code: ETC12838735 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Influenza Vaccines Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Influenza Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Influenza Vaccines Market - Industry Life Cycle |
3.4 Indonesia Influenza Vaccines Market - Porter's Five Forces |
3.5 Indonesia Influenza Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Indonesia Influenza Vaccines Market Revenues & Volume Share, By Strain Type, 2021 & 2031F |
3.7 Indonesia Influenza Vaccines Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Indonesia Influenza Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Indonesia Influenza Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination to prevent influenza |
4.2.2 Growing government initiatives to promote immunization programs |
4.2.3 Rising prevalence of influenza cases in Indonesia |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities, especially in rural areas |
4.3.2 High cost associated with influenza vaccines |
4.3.3 Concerns about the safety and efficacy of vaccines among the population |
5 Indonesia Influenza Vaccines Market Trends |
6 Indonesia Influenza Vaccines Market, By Types |
6.1 Indonesia Influenza Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Influenza Vaccines Market Revenues & Volume, By Vaccine Type, 2021 - 2031F |
6.1.3 Indonesia Influenza Vaccines Market Revenues & Volume, By Inactivated Influenza Vaccine (IIV), 2021 - 2031F |
6.1.4 Indonesia Influenza Vaccines Market Revenues & Volume, By Live Attenuated Influenza Vaccine (LAIV), 2021 - 2031F |
6.1.5 Indonesia Influenza Vaccines Market Revenues & Volume, By Recombinant Influenza Vaccine, 2021 - 2031F |
6.2 Indonesia Influenza Vaccines Market, By Strain Type |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Influenza Vaccines Market Revenues & Volume, By Trivalent Vaccines, 2021 - 2031F |
6.2.3 Indonesia Influenza Vaccines Market Revenues & Volume, By Quadrivalent Vaccines, 2021 - 2031F |
6.3 Indonesia Influenza Vaccines Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Influenza Vaccines Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 Indonesia Influenza Vaccines Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 Indonesia Influenza Vaccines Market Revenues & Volume, By Geriatric, 2021 - 2031F |
6.4 Indonesia Influenza Vaccines Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Indonesia Influenza Vaccines Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.4.3 Indonesia Influenza Vaccines Market Revenues & Volume, By Nasal Spray, 2021 - 2031F |
7 Indonesia Influenza Vaccines Market Import-Export Trade Statistics |
7.1 Indonesia Influenza Vaccines Market Export to Major Countries |
7.2 Indonesia Influenza Vaccines Market Imports from Major Countries |
8 Indonesia Influenza Vaccines Market Key Performance Indicators |
8.1 Vaccination coverage rate in high-risk populations |
8.2 Number of government-funded immunization campaigns |
8.3 Rate of influenza cases reported annually |
8.4 Percentage of healthcare facilities offering influenza vaccinations |
8.5 Public perception and acceptance of influenza vaccination |
9 Indonesia Influenza Vaccines Market - Opportunity Assessment |
9.1 Indonesia Influenza Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Indonesia Influenza Vaccines Market Opportunity Assessment, By Strain Type, 2021 & 2031F |
9.3 Indonesia Influenza Vaccines Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 Indonesia Influenza Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Indonesia Influenza Vaccines Market - Competitive Landscape |
10.1 Indonesia Influenza Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Influenza Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here